Bank of New York Mellon
PASG icon

Bank of New York Mellon’s Passage Bio PASG Stock Holding History

Bank of New York Mellon’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-682
Closed -$13.8K – 4274
2023
Q4 		$13.8K Hold
682
– – ﹤0.01% 4256
2023
Q3 		$8.98K Hold
682
– – ﹤0.01% 4303
2023
Q2 		$12.8K Hold
682
– – ﹤0.01% 4327
2023
Q1 		$13.1K Hold
682
– – ﹤0.01% 4341
2022
Q4 		$18.8K Hold
682
– – ﹤0.01% 4365
2022
Q3 		$17K Sell
682
-253
-27% -$9.97K ﹤0.01% 4467
2022
Q2 		$44K Sell
935
-5,485
-85% -$256K ﹤0.01% 4376
2022
Q1 		$398K Sell
6,420
-35
-0.5% -$2.88K ﹤0.01% 3848
2021
Q4 		$820K Sell
6,455
-9,195
-59% -$1.5M ﹤0.01% 3498
2021
Q3 		$3.12M Buy
15,650
+926
+6% +$221K ﹤0.01% 2749
2021
Q2 		$3.9M Buy
14,724
+672
+5% +$208K ﹤0.01% 2611
2021
Q1 		$4.91M Buy
14,052
+4,657
+50% +$1.99M ﹤0.01% 2452
2020
Q4 		$4.8M Buy
9,395
+1,244
+15% +$498K ﹤0.01% 2379
2020
Q3 		$2.14M Sell
8,151
-460
-5% -$158K ﹤0.01% 2630
2020
Q2 		$4.71M Buy
+8,611
New +$3.87M ﹤0.01% 2232

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon's PASG Position: Q1 2024 in Review

Bank of New York Mellon sold out of Passage Bio (PASG) in Q1 2024, closing a stake of 682 shares — an estimated $13.8K sold.

Bank of New York Mellon first reported a position in PASG in Q2 2020 and held it in 15 quarters. The position peaked at $4.91M in Q1 2021. 48 funds tracked by Wall St. Rank hold PASG as of Q1 2024.

  • Bank of New York Mellon reported no remaining Passage Bio position as of Q1 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 682 Passage Bio shares in Q1 2024, an estimated $13.8K.
  • Bank of New York Mellon first reported a position in Passage Bio in Q2 2020 and held it in 15 quarters.
  • Bank of New York Mellon's Passage Bio position peaked at $4.91M in Q1 2021.
  • 48 funds tracked by Wall St. Rank held Passage Bio as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.